Evaluation of the antiviperine effect of the ethanolic extract of Aristolochia schippii (Standl) against the venoms of Agkistrodon bilineatus and Bothrops asper
DOI:
https://doi.org/10.5377/ri.v1i12.20277Keywords:
Ophidism, Aristolochia schippii, Bothrops asper, Agkistrodon bilineatus, Antiviperins, Antimyotoxic, UPLC-Ms, AntiproteolyticAbstract
This work aimed to evaluate some antiviperin actions of A. schippii against the venoms of A. bilineatus and B. asper and their phytochemical characterization. A qualitative phytochemical march and phytochemical characterization by UPLC-Ms, acute oral toxicity (OECD 423), antihemolytic evaluation in blood agar plates and antiproteolytic in casein, at different venom:extract w/w ratios, and antimyotoxic activity at doses of 600, 900 and 1,200 mg/kg by quantification of CK-MB activity and histology were performed. The results qualitatively evidenced alkaloids, flavonoids, tannins, coumarins, and cardiotonic glycosides, and were detected by UPLC-Ms, aristolochic acid, and a bioactive antheoplastic compound, 10-hydroxycamptothecin; no signs of toxicity or lethality were evidenced at the dose of 2,000 mg/kg. The antihemolytic and antiproteolytic activity decreased significantly (P<0.05), without following a dose-dependent relationship of the venom-extract relationship. The antimyotoxic activity showed partial protection against B. asper at a dose of 600 mg/kg and against A. bilineatus at a dose of 1,200 mg/kg (P<0.05); the histological study showed partial protection due to an improvement in structural organization and low evidence of myonecrosis, as well as the presence of edema in the musculoskeletal system. It is concluded that the ethanolic extract showed the presence of different metabolites such as flavonoids, coumarins, and reducing sugars, while the UPLC-Ms showed the presence of two bioactive components with possible antiviperine activity, such as aristolochic acid and 10-hydroxycamptothecin; also, the extract showed partial protection against hemolytic, proteolytic and myotoxic activities.
264
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.